WASHINGTON, Sept. 16 /PRNewswire-USNewswire/ -- The U.S. Food and Drug
Administration is telling manufacturers of the drug promethazine to include a
boxed warning regarding the injectable form of the drug. The warning, under
FDA's authority to require safety labeling changes, will highlight the risk of
serious tissue injury when this drug is administered incorrectly. The agency
is also alerting health care professionals to the new boxed warning for this
product, which is used as a sedative and to treat nausea and vomiting.
